Karius Overview
- Founded
-
2014

- Status
-
Private
- Employees
-
165

- Latest Deal Type
-
Series B
- Investors
-
14
Karius General Information
Description
Operator of a clinical laboratory testing center intended to focus on generating genomic insights for infectious diseases. The company's tests map each patient's microbial landscape from a single blood draw and develop molecular biology and data analysis tools that use deep sequencing to detect minuscule traces of microbial deoxyribonucleic acid (DNA) directly from blood, enabling physicians to make rapid life-saving treatment decisions in a hassle-free manner.
Contact Information
Website
www.kariusdx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Primary Office
- 975 Island Drive
- Suite 101
- Redwood City, CA 94065
- United States
+1 (866) 000-0000
Karius Timeline
Karius Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
7. Later Stage VC (Series B) | 07-Mar-2022 | 00000 | Completed | Generating Revenue | ||
6. Later Stage VC (Series B) | 20-Jan-2021 | 000 | 00000 | Completed | Generating Revenue | |
5. Later Stage VC (Series B) | 20-Jan-2020 | 00000 | 00000 | Completed | Generating Revenue | |
4. Debt - General | 30-Nov-2018 | 0000 | 000.00 | Completed | Generating Revenue | |
3. Early Stage VC (Series A) | 07-Aug-2017 | 0000 | 000.00 | 00000 | Completed | Generating Revenue |
2. Accelerator/Incubator | $5.27M | Completed | Startup | |||
1. Seed Round | 20-Oct-2014 | $5.27M | $5.27M | 000.00 | Completed | Startup |
Karius Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Seed | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Karius Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a clinical laboratory testing center intended to focus on generating genomic insights for infectious disease
Biotechnology
Redwood City, CA
165
As of 2022
00000
00000000000
00000
Karius Competitors (9)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Adarza BioSystems | Venture Capital-Backed | Saint Louis, MO | 00 | 000.00 | 000000000 - | 000.00 |
0000000 | Formerly VC-backed | San Diego, CA | 000 | 00000 | 000000000 | 00000 |
00000000 0000000 0 | Formerly VC-backed | Castel Maggiore, Italy | 00000 | 000.00 | 000000&0 | 000.00 |
00000000 000000000 | Formerly VC-backed | Seattle, WA | 000 | 00000 | 00000000 | 00000 |
0000 000000 | Formerly VC-backed | Santa Monica, CA | 000 | 00000 | 000000&0 | 00000 |
Karius Patents
Karius Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-3884087-A1 | Detection and prediction of infectious disease | Pending | 21-Nov-2018 | 0000000000 | |
CA-3118742-A1 | Detection and prediction of infectious disease | Pending | 21-Nov-2018 | 0000000000 | |
EP-3884065-A1 | Direct-to-library methods, systems, and compositions | Pending | 21-Nov-2018 | 0000000000 | |
CA-3118990-A1 | Direct-to-library methods, systems, and compositions | Pending | 21-Nov-2018 | 0000000000 | |
EP-3765592-A1 | Sample series to differentiate target nucleic acids from contaminant nucleic acids | Pending | 16-Mar-2018 | C12Q1/6806 |
Karius Executive Team (12)
Karius Board Members (5)
Name | Representing | Role | Since |
---|---|---|---|
Tim Blauwkamp Ph.D | Karius | Co-Founder, Chief Scientific Officer & Board Member | 000 0000 |
Karius Signals
Karius Investors (14)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
General Catalyst | Venture Capital | Minority | 000 0000 | 000000 0 | |
HBM Healthcare Investments | Venture Capital | Minority | 000 0000 | 000000 0 | |
HBM Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
SoftBank Investment Advisers | Growth/Expansion | Minority | 000 0000 | 000000 0 | |
Casdin Capital | Hedge Fund | Minority | 000 0000 | 000000 0 |